College ter Beoordeling van Geneesmiddelen — Tekorten (CBG-MEB)
College ter Beoordeling van Geneesmiddelen — Tekorten is the official source of medicine shortage information for Netherlands (EU). Mederti checks its register daily and links every notice back to the original publication.
- Official register
- www.cbg-meb.nl
- Country
- Netherlands
- Notices tracked by Mederti
- 3,440
- Last checked
- 1 Nov 2026
Latest notices from CBG-MEB
- Pregabaline — active, medium, since 30 Oct 2026 (source)
- Pegvisomant — active, medium, since 30 Oct 2026 (source)
- Dexamfetamine — active, medium, since 30 Oct 2026 (source)
- Liothyronine — active, medium, since 30 Oct 2026 (source)
- Fusidinezuur — active, high, since 30 Oct 2026 (source)
- Barnidipine — active, high, since 30 Oct 2026 (source)
- Rifampicine — active, medium, since 30 Oct 2026 (source)
- Itraconazol — active, medium, since 30 Oct 2026 (source)
- Fenobarbital — active, medium, since 30 Oct 2026 (source)
- Midazolam — active, medium, since 30 Oct 2026 (source)
- Sojaolie, Gezuiverd — active, medium, since 30 Oct 2026 (source)
- Amlodipine — active, medium, since 30 Oct 2026 (source)
- Cabergoline — active, medium, since 30 Oct 2026 (source)
- Valproinezuur — active, medium, since 30 Oct 2026 (source)
- Ropivacaine — active, medium, since 30 Oct 2026 (source)
Every CBG-MEB notice, searchable and alertable
Search Netherlands's full register alongside 50+ other countries — free for individual pharmacists and clinicians.
Create a free accountMederti is not affiliated with or endorsed by College ter Beoordeling van Geneesmiddelen — Tekorten. All notices remain the property of their publisher and are linked to the original source.